India Health Cover Boom: ₹1 Cr Policies Surge on Inflation & Tax Cuts

INSURANCE
Whalesbook Logo
AuthorVihaan Mehta|Published at:
India Health Cover Boom: ₹1 Cr Policies Surge on Inflation & Tax Cuts
Overview

Fueled by escalating medical costs and favorable GST changes, a growing number of Indians are opting for health insurance policies with sum insured of ₹1 crore and above. Insurers like Star Health, Niva Bupa, and HDFC ERGO are witnessing this surge, with high-ticket policies now forming a substantial portion of new business. While this trend signals increased financial protection for consumers, it also places pressure on insurer profitability amidst persistent medical inflation.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

A Growing Trend: High-Value Health Cover Takes Off in India

A significant trend is emerging in India: more consumers are choosing health insurance policies with coverage of ₹1 crore and above. This shift is driven by rising healthcare costs and tax changes that are making higher coverage more affordable. As people seek better financial protection against medical emergencies, insurers are adjusting their plans and sales tactics to meet this growing demand.

Why Demand is Soaring: Medical Costs and Tax Benefits

Medical costs are escalating, projected to rise 11.5% to 14% annually through 2026, changing how consumers approach health insurance. At the same time, Goods and Services Tax (GST) changes, including a potential reduction to 5% or zero for some individual policies starting late 2025, are lowering the overall cost. This combination of rising healthcare expenses and reduced taxes makes higher coverage more achievable. For example, a ₹1-crore policy for a 35-year-old male might cost between ₹18,000 and ₹25,000. Insurers are noting that customers are willing to spend more for better benefits. Star Health and Allied Insurance reported that ₹1-crore-plus policies now make up nearly a quarter of its new business, up 7-8 percentage points from the previous year. Niva Bupa also sees over 20% of new business from policies above ₹1 crore, compared to 5% before. HDFC ERGO is also seeing clients ask about policies worth ₹5-10 crore.

Company Performance and Market Share

Star Health and Allied Insurance, a leading standalone health insurer (SAHI) with roughly 13% market share as of December 2024, has a market capitalization near ₹30,921 crore. Its stock trades at a P/E ratio between 38.4x and 61.00x over the past year and returned 13.46% in the last year. Analysts generally rate it a 'Buy' with an average 12-month price target around ₹528.14. Recent Q4 FY26 results showed a 14% year-over-year increase in net earned premium to INR 43.3 billion, alongside an improved combined ratio of 94.8%.

Niva Bupa Health Insurance held about 9.1% of the retail health market in FY24. It reported a 74% profit jump to ₹208 crore in Q3 FY26, with Gross Written Premium (GWP) up 55% year-on-year, but also posted a ₹8,764 lakh net loss that quarter, showing mixed profitability.

HDFC ERGO General Insurance has a market share of about 5.3% in FY2025, making it a key general insurer. Its health and personal accident segment is its largest contributor, accounting for 38.6% of its Gross Direct Premium (GDPI) in FY2025. However, the company faced challenges with a combined ratio of 112.1% in FY2024, signaling potential profit difficulties.

Industry Growth and Regulatory Changes

The health insurance sector in India is expected to grow strongly, with its market size projected to reach USD 39.5 billion by 2032, growing at a 13.1% compound annual growth rate (CAGR) from 2026-2032. Health insurance is the largest part of the non-life sector, making up over 41% of gross direct premiums in 2024-25.

The Insurance Regulatory and Development Authority of India (IRDAI) has introduced major reforms for 2025-26 to boost transparency and affordability. These include making policies available at any age, limiting pre-existing disease waiting periods to three years, and capping moratorium periods at five years. Additionally, from June 2026, IRDAI will implement performance scorecards for insurers and hospitals, and push for simpler, affordable policy designs. These changes, combined with ongoing medical inflation, create a dynamic market where demand for higher coverage is likely to continue, though insurer profitability will face scrutiny.

Risks for Insurers: Profitability and Valuation

However, several risks require caution despite the demand surge for high-value health plans. Medical inflation, running much higher than general inflation, means claims costs will keep rising for insurers. This directly threatens underwriting profits, especially for companies like HDFC ERGO, which reported a combined ratio of 112.1% in FY2024. While Star Health has improved its underwriting with a 94.8% combined ratio in Q4 FY26, its high P/E ratio of over 56x suggests the market expects strong future growth and efficiency, leaving little room for missteps. Competition is increasing as standalone health insurers (SAHIs) gain market share. New rules pushing for simpler, cheaper policies could also squeeze margins if not handled well. The IRDAI's planned performance scorecards will hold insurers more accountable for claims and efficiency, potentially penalizing underperformers. Any mistakes in managing claims, especially with more high-value policies, could damage investor confidence and lead to sharp drops in valuations.

Looking Ahead: Growth Prospects and Challenges

Analysts expect continued expansion in the Indian health insurance market, with revenue projected to reach USD 62,228.0 million by 2033, driven by a 16.3% CAGR from 2026 to 2033. The trend towards higher sum insured policies is expected to continue, supported by medical inflation and changing consumer demands. Motilal Oswal forecasts Star Health will maintain its lead in retail health, predicting a 32% CAGR in IFRS PAT through FY28.

For the sector, the IRDAI's reform agenda, focused on transparency and accessibility, alongside the potential for increased foreign direct investment (FDI) – with 100% FDI passed in December 2025 – signals a period of rapid change and consolidation. Insurers who can balance growth with profitability and efficiency, while managing a stricter regulatory landscape, are set for long-term success.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.